2.61
2.35%
+0.06
시장 영업 전:
2.69
0.08
+3.07%
전일 마감가:
$2.55
열려 있는:
$2.67
하루 거래량:
1.34M
시가총액:
$393.16M
수익:
$127.04M
순이익/손실:
$-110.56M
주가수익비율:
-2.2308
EPS:
-1.17
순현금흐름:
$-60.33M
1주 성능:
+6.53%
1개월 성능:
+1.56%
6개월 성능:
+247.77%
1년 성능:
+12.02%
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
858-251-4400
주소
4242 Campus Point Court, Suite 200, San Diego, CA
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-05-27 | 개시 | Guggenheim | Buy |
2020-02-20 | 재확인 | Needham | Buy |
2019-01-16 | 재확인 | Needham | Buy |
2018-04-05 | 개시 | Evercore ISI | Outperform |
2018-03-19 | 재확인 | Mizuho | Buy |
2018-03-01 | 재확인 | Needham | Buy |
2018-01-03 | 개시 | Leerink Partners | Outperform |
2017-09-27 | 개시 | Northland Capital | Outperform |
2017-02-27 | 개시 | Needham | Buy |
2016-10-26 | 개시 | Aegis Capital | Buy |
2016-09-06 | 재개 | Lake Street | Buy |
2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
2015-12-10 | 개시 | Lake Street | Buy |
2015-09-23 | 재확인 | Leerink Partners | Outperform |
2015-09-02 | 개시 | BofA/Merrill | Buy |
2015-08-03 | 재확인 | Brean Capital | Buy |
2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
2015-06-19 | 재확인 | Leerink Partners | Outperform |
2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
Zacks Investment Research
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research
Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
Oncternal Therapeutics (ONCT) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Heron Therapeutics Inc (HRTX) 재무 분석
Heron Therapeutics Inc (HRTX) 매출 2024
HRTX은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 127.04M 달러로 보고했으며, 전년대비 +17.99% 상승했습니다.
Heron Therapeutics Inc (HRTX) 순이익 2024
HRTX은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -110.56M 달러로 보고했으며, 전년대비 +39.26% 증가했습니다.
Heron Therapeutics Inc (HRTX) 현금흐름 2024
2023-12-31 종료 분기에 HRTX은 현금흐름(지난 12개월)으로 -60.33M 달러를 기록했으며, 전년 대비 +59.44% 증가했습니다.
Heron Therapeutics Inc (HRTX) 주당 순이익 2024
HRTX이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -0.84달러이며, 전년 대비 +51.45% 성장했습니다.
Heron Therapeutics Inc 주식 (HRTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Collard Craig A | Chief Executive Officer |
Nov 16 '23 |
Buy |
0.92 |
150,000 |
137,970 |
186,496 |
Duarte Ira | EVP, Chief Financial Officer |
Nov 16 '23 |
Buy |
0.89 |
85,000 |
75,599 |
85,000 |
Forbes William P | EVP, Chief Development Officer |
Nov 16 '23 |
Buy |
0.94 |
50,000 |
46,995 |
54,000 |
Morgan Adam | Director |
Jul 21 '23 |
Buy |
1.37 |
2,486,744 |
3,406,839 |
6,986,744 |
자본화:
|
볼륨(24시간):